Patent · US Active

Polypeptides

US9957330B2 · kind B2 · utility

0Cited by

2References

19Claims

0Family size

Assignee

AFFIBODY AB · SE

Inventors

Lars Abrahmsen · Bromma, SE
Ingmarie Höidén-Guthenberg · Sollentuna, SE
Elin Gunneriusson · Hallsberg, SE

Key dates

Filing date	Dec 19, 2013
Grant date	May 1, 2018
Priority date	—
Expiry date	Dec 19, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2318/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to a class of engineered polypeptides having a binding affinity for carbonic anhydrase IX (CAIX), and provides a CAIX binding polypeptide comprising the sequenceThe present disclosure also relates to the use of such a CAIX binding polypeptide as a diagnostic, prognostic agent and/or therapeutic agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.